Joachim Gerß

10.3k total citations · 3 hit papers
154 papers, 4.8k citations indexed

About

Joachim Gerß is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Joachim Gerß has authored 154 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 28 papers in Cardiology and Cardiovascular Medicine and 19 papers in Surgery. Recurrent topics in Joachim Gerß's work include Childhood Cancer Survivors' Quality of Life (12 papers), Acute Kidney Injury Research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Joachim Gerß is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (12 papers), Acute Kidney Injury Research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Joachim Gerß collaborates with scholars based in Germany, United States and Switzerland. Joachim Gerß's co-authors include Alexander Zarbock, Melanie Meersch, Hugo Van Aken, C. G. Schmidt, Carola Wempe, Jacqueline Bauer, John A. Kellum, Dieter Rosenbaum, A. Hoffmeier and Hermann Pavenstädt and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Joachim Gerß

148 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury

2016 641 citations Alexander Zarbock, John A. Kellum et al. profile →
Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial

2017 532 citations Melanie Meersch, Joachim Gerß et al. profile →
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

2022 101 citations Holger Reinecke, Christiane Engelbertz et al. profile →

Peers

Countries citing papers authored by Joachim Gerß

Since Specialization

Citations

This map shows the geographic impact of Joachim Gerß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Gerß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Gerß more than expected).

Fields of papers citing papers by Joachim Gerß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Gerß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Gerß. The network helps show where Joachim Gerß may publish in the future.

Co-authorship network of co-authors of Joachim Gerß

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Gerß. A scholar is included among the top collaborators of Joachim Gerß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Gerß. Joachim Gerß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of propofol or sevoflurane on the renoprotective effect of remote ischaemic preconditioning in cardiac surgery: the HypnoRenalRIP randomised clinical trial 2025 ·British Journal of Anaesthesia ·Alexander Zarbock, (unknown), John A. Kellum, Joachim Gerß, Raphael Weiß, (unknown), Melanie Meersch	1
2	Vaccination status of elite athletes in the German Armed Forces: a retrospective descriptive overview 2025 ·Clinical and Experimental Vaccine Research ·(unknown), (unknown), (unknown), (unknown), Joachim Gerß, Christoph Schulze	0
3	Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events 2025 ·European Journal of Internal Medicine ·(unknown), Robert Radke, Stefan Orwat, Gerrit Kaleschke, (unknown), (unknown), Kevin Willy, Joachim Gerß, Helmut Baumgartner, Gerhard‐Paul Diller, Jeanette Köppe	0
4	Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Sabine Frisch, (unknown), Sarah E. Peters, Joachim Gerß, Katja von Hoff, Rolf‐Dieter Kortmann, Karolina Nemes, Stefan Rutkowski, Martin Hasselblatt, Torsten Pietsch, Michael C. Frühwald, Beate Timmermann	2
5	Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis 2024 ·Journal of Internal Medicine ·Christiane Engelbertz, Ursula Marschall, (unknown), (unknown), (unknown), Eva Freisinger, Joachim Gerß, (unknown), Andreas Faldum, Holger Reinecke, Jeanette Köppe	3
6	Complications and Outcomes in 39,864 Patients Receiving Standard Care Plus Mechanical Circulatory Support or Standard Care Alone for Infarct-Associated Cardiogenic Shock 2024 ·Journal of Clinical Medicine ·Jan-Sören Padberg, (unknown), (unknown), Jeanette Köppe, (unknown), Joachim Gerß, Patrik Dröge, (unknown), Christian Günster, (unknown), Holger Reinecke	4
7	Impact of Guideline-Directed Drug Therapy after ST-Elevation Myocardial Infarction on Outcome in Young Patients—Age and Sex-Specific Factors 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Christian Günster, Patrik Dröge, Christiane Engelbertz, (unknown), Joachim Gerß, Holger Reinecke, Jeanette Köppe	3
8	Contemporary Treatment and Outcome of Patients with Ischaemic Lower Limb Amputation: A Focus on Sex Differences 2023 ·European Journal of Vascular and Endovascular Surgery ·(unknown), Christiane Engelbertz, Jeanette Köppe, Patrik Dröge, (unknown), Christian Günster, Joachim Gerß, Eva Freisinger, Nasser Malyar, Holger Reinecke, (unknown)	3
9	Depression and Anxiety in Heart Transplant Recipients: Prevalence and Impact on Post-Transplant Outcomes 2023 ·Journal of Personalized Medicine ·(unknown), (unknown), Jeanette Köppe, Joachim Gerß, Patrik Dröge, (unknown), Christian Günster, Holger Reinecke, (unknown)	3
10	Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis 2023 ·Cancers ·(unknown), Christoph Schliemann, Christiane Engelbertz, (unknown), (unknown), Joachim Gerß, Patrik Dröge, (unknown), Christian Günster, Holger Reinecke, Jeanette Köppe	2
11	Immunodeficiency is prevalent in congenital heart disease and associated with increased risk of emergency admissions and death 2023 ·European Heart Journal ·Gerhard‐Paul Diller, Astrid E. Lammers, (unknown), Stefan Orwat, (unknown), Renate Schmidt, Robert Radke, (unknown), Gerrit Kaleschke, Ursula Marschall, (unknown), Johannes Roth, Joachim Gerß, Eike Bormann, Helmut Baumgartner	11
12	Digital Breast Tomosynthesis versus Digital Mammography for Detection of Early-Stage Cancers Stratified by Grade: A TOSYMA Subanalysis 2023 ·Radiology ·Stefanie Weigel, Walter Heindel, (unknown), Veronika Weyer‐Elberich, Laura Kerschke, Joachim Gerß, Hans‐Werner Hense, (unknown)	5
13	A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy 2022 ·Annals of Hematology ·(unknown), Raphael Koch, Joachim Gerß, Marcus Hentrich, Rudolf Peceny, Tobias Bartscht, Björn Steffen, (unknown), Karsten Spiekermann, Linus Angenendt, Jan‐Henrik Mikesch, (unknown), Trude Butterfaß‐Bahloul, Hubert Serve, Georg Lenz, Wolfgang E. Berdel, Utz Krug, Christoph Schliemann	1
14	Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial 2022 ·Annals of the Rheumatic Diseases ·Joachim Gerß, (unknown), Ariane Klein, Gerd Horneff, (unknown), Christoph Kessel, Dirk Holzinger, Valda Staņēviča, Joost F. Swart, David A. Cabral, Hermine I. Brunner, Dirk Foell	19
15	Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults 2022 ·Cancer ·(unknown), Claudia Blattmann, Stefan Bielack, Leo Kager, Peter Kaatsch, Thomas Kühne, Benjamin Sorg, Matthias Kevric, Susanne Jabar, Erika Hallmen, Monika Sparber‐Sauer, Thomas Klingebiel, Ewa Kościelniak, Uta Dirksen, Stefanie Hecker‐Nolting, Joachim Gerß	11
16	Acute and Long-Term Outcomes of ST-Elevation Myocardial Infarction in Cancer Patients, a ‘Real World’ Analysis with 175,000 Patients 2021 ·Cancers ·(unknown), (unknown), (unknown), Jeanette Köppe, (unknown), Christiane Engelbertz, Joachim Gerß, Patrik Dröge, (unknown), Christian Günster, Eva Freisinger, Holger Reinecke	3
17	Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data 2021 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Gudrun Würthwein, Claudia Lanvers‐Kaminsky, (unknown), Joachim Gerß, Anja Möricke, Martin Zimmermann, Jan Starý, Petr Smíšek, Martin Schrappe, Carmelo Rizzari, Massimo Zucchetti, Georg Hempel, Sebastian G. Wicha, Joachim Boos	9
18	Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis 2021 ·European Heart Journal ·Astrid E. Lammers, Gerhard‐Paul Diller, (unknown), Mareike Möllers, Renate Schmidt, Robert Radke, (unknown), Gerrit Kaleschke, Ursula Marschall, (unknown), Joachim Gerß, (unknown), Helmut Baumgartner	38
19	Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis 2019 ·European Heart Journal ·Eva Freisinger, Jeanette Koeppe, Joachim Gerß, Dennis Göerlich, Nasser Malyar, Ursula Marschall, Andreas Faldum, Holger Reinecke	124
20	Advance (Meta-) Directives for Patients with Dementia who Appear Content: Learning from a Nationwide Survey 2016 ·Journal of the American Medical Directors Association ·Bettina Schöne-Seifert, (unknown), Joachim Gerß, David W. Herr	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact